Pinpoint radiation offers new hope for inoperable kidney cancer

NCT ID NCT07285538

Summary

This study is testing a highly precise form of radiation therapy for people with kidney cancer who are not good candidates for surgery. The main goal is to see if this targeted approach can effectively control the cancer while causing fewer side effects. It will involve 60 participants and follow them for three years to track outcomes and quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Radiation Oncology, IRCCS San Raffaele Scientific Institute

    Milan, Milano (MI), 20073, Italy

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.